Michele Del Zingaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michele Del Zingaro has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Ettore Mearini
Department of Medicine and Surgery, Urology Clinic, University of Perugia, 06129 Perugia, Italy
7 shared publications - Giovanni Cochetti
Department of Medicine and Surgery, Urology Clinic, University of Perugia, 06129 Perugia, Italy
7 shared publications - Andrea Paladini
Radiology Institute, Services Diagnosis and Therapies Department, Maggiore della Carità Hospital, University of Eastern Piedmont - UPO University, Corso G. Mazzini 18, 28100 Novara, Italy
4 shared publications A. Tiezzi
3 shared publications- Giuseppe Maiolino
Lyx Institute of Urology, Universidad Francisco de Vitoria, Madrid, Spain
3 shared publications - Graziano Felici
Urology Clinic, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy
3 shared publications
Latest Publications
- 10 February 2022
- Published by Wiley in International Journal of Urological Nursing
- Vol. 16 (1) , 65-66
Post‐void residual volume after uroflowmetry measured using both ultrasound and bladder scanner by urologic nurses
- 10 February 2022
- Published by Wiley in International Journal of Urological Nursing
- Vol. 16 (1) , 65-66
Post‐void residual volume after uroflowmetry measured using both ultrasound and bladder scanner by urologic nurses
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S1642
Full neurovascular sparing extraperitoneal robotic radical prostatectomy: A single center experience with PERUSIA technique
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S1642
Full neurovascular sparing extraperitoneal robotic radical prostatectomy: A single center experience with PERUSIA technique
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S656-S657
Positive uroflow stop test with EMG may predict potency recovery after RARP
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S656-S657
Positive uroflow stop test with EMG may predict potency recovery after RARP
- Open Access
- 1 January 2021
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 12 (1) , e34
Holmium:YAG Laser for the Treatment of Genital and urethral Warts: Multicentre Prospective Evaluation of Safety and Efficacy
Introduction: Genital condylomatosis is a highly contagious disease caused by the human papilloma virus (HPV). The aim of this prospective multicentre study was to evaluate the safety and efficacy of the Holmium:YAG (yttrium-aluminium-garnet) laser in the treatment of genital and intra-urethral warts; the secondary aim was to assess the patients’ postoperative satisfaction and cosmetic results. Methods: From December 2016 to March 2019, patients with genital warts were prospectively enrolled in three hospitals. The inclusion criteria were male gender, age over 18 years-old and treatment-naïve. External and urethral genitalia warts were treated by the Holmium YAG laser. The follow-up analysis consisted of physical examination, flexible urethro-cystoscopy in case of meatal lesions, and administration of Dermatology Quality of Life Index (DLQI) and Patient Global Impression of Improvement (PGI-I) questionnaires at 1, 3, 6 and 12 months after surgery and subsequently yearly. Results: Sixty patients were enrolled. The single treatment was effective in 57/60 patients (95%). At a mean follow-up of 26 months, recurrences occurred in 8 patients (13.3%). No peri- or post-operative complication occurred. An improvement in pre-operative condition was highlighted with PGI-I and DLQI questionnaires. Conclusion: Our prospective multicentre study showed that holmium laser surgery seems to be a safe and effective treatment for external genital and urethral warts. Good dermatological outcomes aid to further improve patient satisfaction.
- 1 January 2021
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 12 (1) , e34
Open AccessHolmium:YAG Laser for the Treatment of Genital and urethral Warts: Multicentre Prospective Evaluation of Safety and Efficacy
Introduction: Genital condylomatosis is a highly contagious disease caused by the human papilloma virus (HPV). The aim of this prospective multicentre study was to evaluate the safety and efficacy of the Holmium:YAG (yttrium-aluminium-garnet) laser in the treatment of genital and intra-urethral warts; the secondary aim was to assess the patients’ postoperative satisfaction and cosmetic results. Methods: From December 2016 to March 2019, patients with genital warts were prospectively enrolled in three hospitals. The inclusion criteria were male gender, age over 18 years-old and treatment-naïve. External and urethral genitalia warts were treated by the Holmium YAG laser. The follow-up analysis consisted of physical examination, flexible urethro-cystoscopy in case of meatal lesions, and administration of Dermatology Quality of Life Index (DLQI) and Patient Global Impression of Improvement (PGI-I) questionnaires at 1, 3, 6 and 12 months after surgery and subsequently yearly. Results: Sixty patients were enrolled. The single treatment was effective in 57/60 patients (95%). At a mean follow-up of 26 months, recurrences occurred in 8 patients (13.3%). No peri- or post-operative complication occurred. An improvement in pre-operative condition was highlighted with PGI-I and DLQI questionnaires. Conclusion: Our prospective multicentre study showed that holmium laser surgery seems to be a safe and effective treatment for external genital and urethral warts. Good dermatological outcomes aid to further improve patient satisfaction.
- 9 October 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (9) , e3187
Renal artery embolization before radical nephrectomy for complex renal tumor: Which are the true advantages?
- 9 October 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (9) , e3187
Renal artery embolization before radical nephrectomy for complex renal tumor: Which are the true advantages?
- 1 September 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (6) , e2669-e2670
Laparoscopic or robotic adrenalectomy for adrenal mass? A multicenter prospective study
- 1 September 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (6) , e2669-e2670
Laparoscopic or robotic adrenalectomy for adrenal mass? A multicenter prospective study
- 1 September 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (6) , e2671-e2674
Evaluation of perioperative outcomes from a case series of robotic treatment of colo-vesical fistula without bowel resection
- 1 September 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (6) , e2671-e2674
Evaluation of perioperative outcomes from a case series of robotic treatment of colo-vesical fistula without bowel resection